Participants 40 81 6
patients with fibrocystic breast disease]
Participants 156 193 6
patients with fibrocystic mastopathy.
Participants 215 356 6
Patients with diagnosis of fibrocystic breast disease were included in a prospective longitudinal blind double, controlled with placebo study
Participants 749 811 4
39 patients with alpha dihidroergocriptine and 38 with placebo
Participants 1665 1692 4
fribrocystic breast disease
